Suppr超能文献

[结核菌素对实验性结核病临床病程及愈合过程的影响]

[Effect of tuberculin on the clinical course and healing processes in experimental tuberculosis].

作者信息

Krylov V A, Titov V F, Tereshin V S

出版信息

Probl Tuberk. 1994(4):41-4.

PMID:7984615
Abstract

Two procedures for treating experimental tuberculosis were compared. One comprised a rapid administration of tuberculin up to large doses (20,000 TE), the other included weakly stimulating therapy with tuberculin (its maximum dose being 150 TE). Treatment with tuberculin in combination with isoniazid ensures a higher resolution of specific abnormalities than that with isoniazid alone. However, when either procedures were used, the weakly stimulating procedure led to experimental animals' death, which generates the need to take a preliminary account of the body's response to tuberculin in the clinical setting in order to choose tuberculin therapy on an individual basis.

摘要

对两种治疗实验性结核病的方法进行了比较。一种方法是快速给予大剂量(20,000结核菌素单位)的结核菌素,另一种方法是用结核菌素进行弱刺激疗法(最大剂量为150结核菌素单位)。与单独使用异烟肼相比,结核菌素联合异烟肼治疗能使特定异常情况得到更高的缓解率。然而,无论采用哪种方法,弱刺激疗法都会导致实验动物死亡,这就需要在临床环境中预先考虑机体对结核菌素的反应,以便进行个体化的结核菌素治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验